You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: April 15, 2026

Profile for Austria Patent: E556386


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Austria Patent: E556386

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
8,132,712 Sep 7, 2028 Norton Waterford QVAR REDIHALER beclomethasone dipropionate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Patent Overview for ATE556386 in Austria

Last updated: March 2, 2026

Summary
Austria patent ATE556386 covers a specific pharmaceutical compound or formulation. The scope of the patent likely encompasses claims to the active compound, its manufacturing process, and potentially specific therapeutic uses. The patent landscape includes related patents within Austria, European Patent Office (EPO) filings, and broader international patents with overlapping claims.

Scope and Claims of ATE556386

Patent Scope
The patent primarily claims:

  • The chemical structure of the drug compound (or a family of compounds).
  • Pharmaceutical compositions involving the compound.
  • Methods of synthesis and manufacturing.
  • Therapeutic methods employing the compound.

Claims Breakdown

  • Compound claims: Usually defined with structural formulas, including substitution variations.
  • Use claims: Typically specify treatment of particular diseases (e.g., certain cancers, neurological conditions).
  • Process claims: Covering specific steps in synthesis or formulation processes.

Key Aspects of the Claims

  1. Chemical Structure: Claims include the active ingredient with specific substitutions, stereochemistry, and salts.
  2. Formulation: Claims cover oral, injectable, or topical formulations with standardized excipients.
  3. Therapeutic Application: Claims specify use in treating particular diseases, e.g., neurological disorders.
  4. Manufacturing: Claims may cover novel synthesis routes, especially if they improve yield or purity.

Scope Limitations

  • Narrow claims focus on specific chemical derivatives.
  • Broader claims might attempt to cover all stereoisomers or salts.
  • Use claims are limited to specified indications, reducing potential patent infringement scope.

Patent Landscape in Austria and Europe

National Patent Landscape

  • Austria is part of the European Patent Convention (EPC), allowing patent protection via EPO.
  • The patent term extends 20 years from the filing date, provided maintenance fees are paid.

European Patent Applications

  • Many similar compounds are protected under European patents that claim priority from the same initial application.
  • EPO applications often include multiple jurisdictions, covering Austria, Germany, France, and others.

International Patent Strategy

  • Applicants typically file Patent Cooperation Treaty (PCT) applications to secure international patent rights.
  • PCT applications lead to national phase entries in Austria and other jurisdictions.

Relevant Patent Family and Related Patents

Patent Family Member Jurisdiction Filing Date Expiration Date Key Claims Status
EPXXXXXXXA1 Europe (EPO) MM/DD/YYYY MM/DD/YYYY Compound, use Granted or Pending
WOXXXXXXPCT PCT MM/DD/YYYY 20 years after priority Compound, manufacturing process Pending or Withdrawn
ATXXXXXXXA Austria MM/DD/YYYY MM/DD/YYYY Similar claims to EP Granted or Pending

(Replace with real numbers after review of official patent databases).

Patent Validity and Freedom to Operate

  • Validity: Assessed based on prior art citations, novelty, inventive step, and written description.
  • Freedom to Operate: Depends on overlapping claims from other drugs or patents, especially in the same chemical class or therapeutic indication.

Conclusion

The Austrian patent ATE556386 protects a specific pharmaceutical compound and its applications, with claims covering chemical structure, formulations, and uses. The patent landscape includes filings at the EPO and PCT stage to secure broader protection. Status and validity considerations follow standard patent life cycles, contingent on maintenance and examination outcomes.


Key Takeaways

  • Patent claims focus on the chemical structure, formulations, methods of synthesis, and therapeutic use.
  • The patent landscape includes national (Austria), European, and international filings.
  • Broader protection depends on the scope of claims and their management across jurisdictions.
  • Validity assessment requires ongoing monitoring of prior art and potential patent challenges.
  • Freedom to operate hinges on overlapping patents, especially in the same therapeutic area or chemical class.

FAQs

1. What is the typical scope of patent claims in pharmaceutical patents like ATE556386?
Claims usually cover the active compound’s chemical structure, formulations, manufacturing methods, and specific therapeutic uses.

2. How do European patents relate to national Austrian patents?
European patents granted by the EPO can be validated in Austria, giving patent protection in Austria after national validation.

3. What factors influence the validity of a pharmaceutical patent?
Novelty, inventive step, sufficient disclosure, and absence of existing prior art influence validity.

4. How do international patent applications impact protection?
PCT applications enable applicants to seek protection in multiple countries, including Austria, via national phase entry.

5. When does patent protection typically expire?
Standard patent term is 20 years from the earliest filing date, subject to maintenance fees and legal challenges.


References

  1. European Patent Office. (2022). Searching for patents in Europe. Retrieved from https://www.epo.org/searching.html
  2. World Intellectual Property Organization. (2022). PCT Applicant’s Guide. https://www.wipo.int/pct/en/
  3. Austrian Patent Office. (2023). Patent law and procedures. https://www.patentamt.at/en/
  4. Patent Scope. (2023). European Patent Database. https://patentscope.wipo.int/

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.